Atlas Trials

MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer

Clinical trial NCT00403429 · COMPLETED

Trial details

NCT number
NCT00403429
Sponsor
National Cancer Institute, Naples
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2006-03-01
Primary completion
2008-01-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.